FDA panel backs 'morning-after pill'

Plan B over the counter

Cheers and criticism have followed a Food and Drug Administration panel recommendation that the so-called morning-after pill be made available over the counter. The panel voted 23-4 that the drug, also known as Plan B, should be made available without a prescription.

Barr Laboratories, a New Jersey–based pharmaceutical company seeking the new status for the drug, said Plan B can prevent 95 percent of expected pregnancies when it is taken within 24 hours of unprotected intercourse.

FDA officials are expected to make a final decision “in a matter of months,” said spokesman Jason Brodsky.


This article is available to subscribers only. Please subscribe for full access—subscriptions begin at $2.95. Already have an online account? Log in now. Already a print subscriber? Create an online account for no additional cost.

This article is available to subscribers only.

To post a comment, log inregister, or use the Facebook comment box.